The patent badge is an abbreviated version of the USPTO patent document. The patent badge does contain a link to the full patent document.

The patent badge is an abbreviated version of the USPTO patent document. The patent badge covers the following: Patent number, Date patent was issued, Date patent was filed, Title of the patent, Applicant, Inventor, Assignee, Attorney firm, Primary examiner, Assistant examiner, CPCs, and Abstract. The patent badge does contain a link to the full patent document (in Adobe Acrobat format, aka pdf). To download or print any patent click here.

Date of Patent:
Nov. 21, 2017

Filed:

Jun. 12, 2015
Applicant:

Whitehead Institute for Biomedical Research, Cambridge, MA (US);

Inventors:

Aftabul Haque, Belmont, MA (US);

Susan L. Lindquist, Cambridge, MA (US);

Assignee:
Attorney:
Primary Examiner:
Int. Cl.
CPC ...
C12N 15/81 (2006.01); C07K 14/47 (2006.01); C12N 15/85 (2006.01); G01N 33/50 (2006.01);
U.S. Cl.
CPC ...
C07K 14/4711 (2013.01); C12N 15/81 (2013.01); C12N 15/85 (2013.01); G01N 33/5014 (2013.01); C07K 2319/02 (2013.01); C12N 2740/16043 (2013.01); C12N 2800/22 (2013.01); C12N 2830/003 (2013.01); C12N 2830/008 (2013.01); G01N 2333/4709 (2013.01); G01N 2500/10 (2013.01); G01N 2800/2821 (2013.01);
Abstract

Disclosed are yeast expression constructs encoding a polypeptide containing a signal sequence, a Golgi-directing pro sequence, and a human amyloid beta protein, and mammalian expression constructs encoding a polypeptide containing a selected signal sequence and a human amyloid beta protein. Also disclosed are methods of screening cells to identify compounds that prevent or suppress amyloid beta-induced toxicity and genetic suppressors or enhancers of amyloid beta-induced toxicity. Compounds identified by such screens can be used to treat or prevent neurodegenerative disorders such as Alzheimer's disease.


Find Patent Forward Citations

Loading…